Eva Medtec, with a valuation of $8.9 million, is raising funds on NetCapital. The company has developed an at-home automated lymphatic therapy system. It has created and manufactured Neuroglide, an over-the-counter, FDA-cleared medical device that is engineered to automate and emulate manual lymphatic drainage (MLD) therapy. Neuroglide uses a calibrated pressure profile to remove cellular waste associated with inflammatory circulatory conditions and improve life quality. Irene Anne Waldridge founded Eva Medtec in July 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $487,500. The campaign proceeds will be used for sales and marketing, operations, inventory, clinical studies, and new product development.